Related references
Note: Only part of the references are listed.Anti-Inflammatory Screening and Molecular Modeling of Some Novel Coumarin Derivatives
Radwan El-Haggar et al.
MOLECULES (2015)
Synthesis and biological evaluation of new pyrazolone-pyridazine conjugates as anti-inflammatory and analgesic agents
Nadia Abdalla Khalil et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Benzimidazole: An emerging scaffold for analgesic and anti-inflammatory agents
Monika Gaba et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
The therapeutic journey of benzimidazoles: A review
Yogita Bansal et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Synthesis and pharmacological evaluation of novel 5-substituted-1-(phenylsulfonyl)-2-methylbenzimidazole derivatives as anti-inflammatory and analgesic agents
Monika Gaba et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
One-Pot Synthesis of Five and Six Membered N, O, S-Heterocycles Using a Ditribromide Reagent
Ramesh Yella et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2010)
Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks
Inger L. Meek et al.
PHARMACEUTICALS (2010)
Nonsteroidal anti-inflammatory drugs in experimental parkinsonian models and Parkinson's disease
Masato Asanuma et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): Cyclooxygenase (COX) inhibition and beyond
P. N. Praveen Rao et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2008)
NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies
Patrick L. McGeer et al.
NEUROBIOLOGY OF AGING (2007)
Cyclooxygenase-2 as a target for anticancer drug development
Jean-Baptiste Meric et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
Practice pointer - Understanding the NSAID related risk of vascular events
HE Vonkeman et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
RS Bresalier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
CoMFA/CoMSIA/HQSAR and docking study of the binding mode of selective cyclooxygenase (COX-2) inhibitors
HF Chen et al.
QSAR & COMBINATORIAL SCIENCE (2004)
On the tautomerism of pyrazolones:: the geminal 2J[pyrazole C-4,H-3(5)] spin coupling constant as a diagnostic tool
W Holzer et al.
TETRAHEDRON (2004)
Synthesis and NMR spectroscopic investigations with 3-amino-, 3-hydroxy-, and 3-methoxy-4-acyl-1-phenyl-2-pyrazolin-5-ones
W Holzer et al.
HETEROCYCLES (2004)
Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications - review and recommendations based on risk assessment
FKL Chan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
COX-3: a splice variant of cyclooxygenase-1 in mouse neural tissue and cells
SS Shaftel et al.
MOLECULAR BRAIN RESEARCH (2003)
A novel mechanism of cyclooxygenase-2 inhibition involving interactions with Ser-530 and Tyr-385
SW Rowlinson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs
C Charlier et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)
Design, synthesis and biological evaluation of benzimidazole/benzothiazole and benzoxazole derivatives as cyclooxygenase inhibitors
R Paramashivappa et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Cyclooxygenase 2: a molecular target for cancer prevention and treatment
K Subbaramaiah et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression
NV Chandrasekharan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Evaluation of selective COX-2 inhibitors for the treatment of Alzheimer's disease
PS Aisen
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2002)
Cyclooxygenase enzymes: catalysis and inhibition
RG Kurumbail et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2001)
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer
AJ Dannenberg et al.
LANCET ONCOLOGY (2001)
Cyclooxygenase inhibitors - current status and future prospects
G Dannhardt et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2001)
The pyrrole moiety as a template for COX-1/COX-2 inhibitors
G Dannhardt et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2000)